Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a publicly traded Healthcare sector company. As of October 19, 2026, MDGL trades at $452.09 with a market cap of $10.39B and a P/E ratio of -38.41. MDGL moved +0.52% today. Year to date, MDGL is -22.77%; over the trailing twelve months it is +1.72%. Its 52-week range spans $265.00 to $615.00. Analyst consensus is strong buy with an average price target of $684.50. Rallies surfaces MDGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MDGL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MDGL recently traded at $452.09. Market cap is $10.39B. P/E ratio is -38.41. Revenue is $958.40M.
| Metric | Value |
|---|---|
| Price | $452.09 |
| Market Cap | $10.39B |
| P/E Ratio | -38.41 |
| EPS | $-12.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $615.00 |
| 52-Week Low | $265.00 |
| Volume | 46 |
| Avg Volume | 0 |
| Revenue (TTM) | $958.40M |
| Net Income | $-288.28M |
| Gross Margin | 0.00% |
12 analysts cover MDGL: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $684.50.